Literature DB >> 26675502

Recurrent gastric neuroendocrine tumors treated with total gastrectomy.

Myounghwa Jung1, Jung-Wook Kim1, Jae-Young Jang1, Young Woon Chang1, Sun Hee Park1, Yong Ho Kim1, Youn Wha Kim1.   

Abstract

Gastric neuroendocrine tumors are rare; however, the incidence has recently increased due to the increasing use of upper endoscopy. Neuroendocrine tumors arise from the excess proliferation of enterochromaffin-like (ECL) cells. The proliferative changes of enterochromaffin cells evolve through a hyperplasia-dysplasia-neoplasia sequence that is believed to underlie the pathogenesis of gastric neuroendocrine tumors. Endoscopic resection is recommended as the initial treatment if the tumor is not in an advanced stage. However, there is no definite guideline for the treatment of recurrent gastric neuroendocrine tumors following endoscopic resection. Here, we report a rare case of gastric neuroendocrine tumors in a 56-year-old male who experienced two recurrences within 11 years after endoscopic resection. The patient finally underwent a total gastrectomy. The pathological features of the resected stomach exhibited the full hyperplasia-dysplasia-neoplasia sequence of the ECL cells in a single specimen.

Entities:  

Keywords:  Dysplasia of neuroendocrine cell; Hyperplasia of neuroendocrine cell; Neuroendocrine tumor; Total gastrectomy

Mesh:

Substances:

Year:  2015        PMID: 26675502      PMCID: PMC4674739          DOI: 10.3748/wjg.v21.i46.13195

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  15 in total

1.  ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms.

Authors:  Gianfranco Delle Fave; Dik J Kwekkeboom; Erik Van Cutsem; Guido Rindi; Beata Kos-Kudla; Ulrich Knigge; Hironobu Sasano; Paola Tomassetti; Ramon Salazar; Philippe Ruszniewski
Journal:  Neuroendocrinology       Date:  2012-02-15       Impact factor: 4.914

2.  Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate.

Authors:  Elettra Merola; Andrea Sbrozzi-Vanni; Francesco Panzuto; Giancarlo D'Ambra; Emilio Di Giulio; Emanuela Pilozzi; Gabriele Capurso; Edith Lahner; Cesare Bordi; Bruno Annibale; Gianfranco Delle Fave
Journal:  Neuroendocrinology       Date:  2011-07-30       Impact factor: 4.914

Review 3.  Histopathological classification of nonantral gastric endocrine growths in man.

Authors:  E Solcia; C Bordi; W Creutzfeldt; Y Dayal; A D Dayan; S Falkmer; L Grimelius; N Havu
Journal:  Digestion       Date:  1988       Impact factor: 3.216

4.  Multiple gastric carcinoids associated with hypergastrinemia. A review of five cases with clinicopathological analysis and surgical strategies.

Authors:  Ken-Ichi Okada; Hiroshi Kijima; Osamu Chino; Masahiro Matsuyama; Yuichi Okamoto; Soichiro Yamamoto; Makiko Tanaka; Sadaki Inokuchi; Hiroyasu Makuuchi
Journal:  Anticancer Res       Date:  2005 Nov-Dec       Impact factor: 2.480

5.  Usefulness of laparoscope-assisted antrectomy for gastric carcinoids with hypergastrinemia.

Authors:  Masato Hoshino; Nobuo Omura; Fumiaki Yano; Kazuto Tsuboi; Akira Matsumoto; Se Ryung Yamamoto; Syunsuke Akimoto; Hideyuki Kashiwagi; Katsuhiko Yanaga
Journal:  Hepatogastroenterology       Date:  2010 Mar-Apr

Review 6.  Review of the pathogenesis, diagnosis, and management of type I gastric carcinoid tumor.

Authors:  Linda Zhang; Junko Ozao; Richard Warner; Celia Divino
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

Review 7.  Interventional treatment of gastrointestinal neuroendocrine tumours.

Authors:  H Ahlman; B Wängberg; S Jansson; S Friman; M Olausson; U Tylén; O Nilsson
Journal:  Digestion       Date:  2000       Impact factor: 3.216

Review 8.  Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal.

Authors:  Lucy Vannella; Edith Lahner; Bruno Annibale
Journal:  World J Gastroenterol       Date:  2012-03-28       Impact factor: 5.742

Review 9.  Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?

Authors:  H Scherübl; G Cadiot; R T Jensen; T Rösch; U Stölzel; G Klöppel
Journal:  Endoscopy       Date:  2010-07-28       Impact factor: 10.093

Review 10.  Review article: the investigation and management of gastric neuroendocrine tumours.

Authors:  R Basuroy; R Srirajaskanthan; A Prachalias; A Quaglia; J K Ramage
Journal:  Aliment Pharmacol Ther       Date:  2014-03-13       Impact factor: 8.171

View more
  1 in total

1.  Insights into gastric neuroendocrine tumors burden.

Authors:  Taíssa Maíra Thomaz Araújo; Williams Fernandes Barra; André Salim Khayat; Paulo Pimentel de Assumpção
Journal:  Chin J Cancer Res       Date:  2017-04       Impact factor: 5.087

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.